                               SEQUENCE LISTING

<110> VITRISA THERAPEUTICS, INC.
 
<120> PEGYLATED COMPOSITIONS FOR OCULAR USE, AND METHODS THEREOF

<130> 49644-721.601

<140>
<141>

<150> 62/663,001
<151> 2018-04-26

<160> 5     

<170> PatentIn version 3.5

<210> 1
<211> 40
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide

<400> 1
ccgccuugcc aguauuggcu uaggcuggaa guuuggcggt                             40


<210> 2
<211> 40
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide

<400> 2
ccgccuugcc aguauuggcu uaggcuggaa guuuggcggt                             40


<210> 3
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide

<400> 3
cgccgcgguc ucaggcgcug agucugaguu uaccugcgt                              39


<210> 4
<211> 35
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
gggggcuuau cauuccauuu aguguuauga uaacc                                  35


<210> 5
<211> 33
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
ggucuagccg gaggagucag uaaucgguag acc                                    33


